Healthcare companies leverage social media to educate patients, promote wellness, and spotlight medical innovations.
In the last 30 days, the average company in this landscape has grown their audience by 0.5%. Bristol Myers Squibb grew faster than everyone else, with 2.8% growth! On average, each post in this landscape earns more than 187.7 engagements. Abbott is topping the charts with more than 938.0 engagements per post on their 31 posts in the last 30 days.
Protein is having its moment — and for good reason. Our expert is cutting through the noise to break down how much protein is really recommended, when to refuel after a workout and simple ways to build balanced meals. And for those looking to boost their protein intake, solutions like ensure Max Protein 2-in-1 Muscle Support …
Your immune system is remarkably powerful, designed to protect and defend. However, in rare cases during pregnancy, maternal antibodies can mistakenly target fetal blood cells or platelets, leading to serious conditions. We’re researching potential breakthrough therapies to help reduce these risks. Our goal: healthy babies born without complications. Learn more about our progress at the link …
Short on time but looking for a career change? On our job search site, you can explore thousands of meaningful roles, filter by what you care about, save jobs you like, and use a saved resume or autofill from LinkedIn for your application. Get started at the link in our bio. #JobSearch #Hiring
We heard that the ‘90s are back… :-) (We don’t sell Pedialyte Singles anymore, but we do have half liters for your dehydration needs!)
Half of the global population is at risk of a Dengue infection. Over the past 50 years, the spread of the disease has accelerated, posing a significant global health threat as half of the world's population now lives in areas at risk of infection - and climate change is speeding things up. What makes dengue particularly …
C3 glomerulopathy (C3G) is a rare, progressive kidney disease that can have serious long‑term consequences. About 1 in 2 people with C3G may face kidney failure within 10 years, often requiring lifelong dialysis or a kidney transplant. The images in this post highlight why C3G can be so difficult to detect. Its symptoms often resemble those …
IgA nephropathy (IgAN) is a chronic autoimmune kidney disease that can silently damage the kidneys over time. Around 25 people per million worldwide are diagnosed each year — yet many remain unaware they have the disease until kidney damage has already progressed. The images in this post explain why IgAN can be difficult to detect. Symptoms …
Meet Corinne — a wife, mother of two, friend to many and a multiple myeloma survivor. During #MyelomaActionMonth, we traveled to her home in Florida to capture her inspiring story of learning how to embrace the present while navigating life as a cancer survivor with a chronic condition. Follow along to watch her full video later …
For many cancer patients in America, the nearest major research hospital is hours away. But what if groundbreaking clinical trials were right in their communities instead? Karin Choquette, AVP of Research Site Operations at Sarah Cannon Research Institute, is working to make that vision a reality. In the latest episode of Coffee + Connection, she …
Columbus, big things are happening ❤️ With support from the CVS Health Foundation, a new CVS Health Zone has launched with HealthImpactOhio. This work brings support closer to home by connecting families with primary care, nutritious food and everyday health resources. What does it look like when care is built around the community? Learn more about how this work …
This installment of our I+I series features Martina Kopp, a leader whose journey has been defined by resilience and authenticity. Having navigated barriers through her own experience with hearing loss, Martina approaches difficult tasks with determination and creativity. As a global chapter liaison for Gilead’s disability inclusion employee resource group, she believes that when individuals are …
The pace of cancer research has never been faster. The challenge now is making sure that progress reaches patients—using tools like #AI to help navigate complexity across cancer care. In our season finale of #ScienceWillWin, Dr. raventhesciencemaven explores how AI in #oncology can support the decisions patients and clinicians face—from clinical trials to access to care. Head …
Protein is having its moment — and for good reason. Our expert is cutting through the noise to break down how much protein is really recommended, when to refuel after a workout and simple ways to build balanced meals. And for those looking to boost their protein intake, solutions like Ensure Max Protein 2-in-1 Muscle Support …
Check out this week's Extra Big Deals! Use your ExtraCare card to get these deals March 29 to April 4, online and in store.
We heard that the ‘90s are back… :-) (We don’t sell Pedialyte Singles anymore, but we do have half liters for your dehydration needs!)
Meet Corinne — a wife, mother of two, friend to many and a multiple myeloma survivor. During #MyelomaActionMonth, we traveled to her home in Florida to capture her inspiring story of learning how to embrace the present while navigating life as a cancer survivor with a chronic condition. Follow along to watch her full video later …
C3 glomerulopathy (C3G) is an ultra-rare disease that can progress to kidney failure over time. Because early symptoms can be subtle or mistaken for other kidney conditions, C3G is often diagnosed late—when irreversible damage may have already occurred. Recognizing the warning signs sooner can make a real difference. Could you or someone you care about be missing …
IgA nephropathy (IgAN) is one of the most common kidney diseases affecting the kidney’s filters, yet it often goes undetected. Early symptoms can be mild and easy to dismiss—leaving many people unaware of what’s happening inside their kidneys until damage has progressed. As understanding of IgAN continues to evolve, knowing how the disease develops and progresses …
Your immune system is remarkably powerful, designed to protect and defend. However, in rare cases during pregnancy, maternal antibodies can mistakenly target fetal blood cells or platelets, leading to serious conditions. We’re researching potential breakthrough therapies to help reduce these risks. Our goal: healthy babies born without complications. Learn more: https://social.jnj.com/4sM668o For U.S. Audience Only
Not sure if it's perimenopause or something else? Here are some signs. For more click here: https://cvs.co/4s9ukID
Biologics was proud to join McKesson MID at the 22nd Hematology/Oncology Pharmacy Association - HOPA Annual Conference in New Orleans this month! It was a great chance to meet with our peers and learn about the latest trends in pharmacy. This year's theme was “We March On," a reminder to meet challenges head-on to ensure that …
Science is fueled by curiosity and resilience - and for Susagna, these two qualities have defined her journey. 🧬✨ At Roche, we know that the most meaningful progress happens when inclusion is more than just a conversation; it’s part of our daily lives. Creating a truly inclusive culture means valuing every ability and every unique way …
We deliver innovation that changes the trajectory of serious diseases. Fast Company named Gilead as the #1 Most Innovative Company in Medicines, Therapeutics and Pharmaceuticals for 2026, recognizing our twice‑yearly HIV prevention medicine as a breakthrough our innovative manufacturing and distribution practices enabling availability and access where it’s most needed. This achievement is powered by our extraordinary …
One of the most powerful steps you can take when living with a rare condition like transthyretin cardiac amyloidosis or ATTR-CM is to be your own best advocate, and look for a doctor you can count on. That's the shared advice from patients and caregivers, whose experiences highlight the importance of being proactive in your health …
15 Likes • 1 Retweets
#MEDIA: We’re showcasing full Phase 3 SCOUT‑HCM results at #ACC26, highlighting a potential treatment option for adolescents with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Learn more about the data: bit.ly/4theMDz pic.x.com/PWXVVQ3cUR
13 Likes • 1 Retweets
Advancing what’s possible in cancer care includes transforming what’s possible for testing. Congratulations to our new cancer diagnostics colleagues from Exact Sciences for being recognized on the @FastCompany Most Innovative Companies biotech list. abbo.tt/47r9rBh pic.x.com/AMERIy0SXX
12 Likes • 2 Retweets
MEDIA: At this year’s #SIRS2026, we’re presenting abstracts from our neuroscience portfolio, including new #schizophrenia data. Learn more here: bit.ly/4uUgEDM pic.x.com/Buz0hoHDyb
7 Likes • 2 Retweets
Dr. Tester F. Ashavaid acknowledged that, in one of their studies, more than 50% of patients receiving the standard dose were sub-therapeutic. Mass spectrometry can bridge this gap, supporting Therapeutic Drug Monitoring (TDM) to give clinicians precise, actionable insights. pic.x.com/cPSRKyzgRf
6 Likes • 0 Retweets
#MEDIA: Today, we announced the expansion of Standing in the Gaap, marking 10 years of work to address gaps and barriers in multiple myeloma care—including plans to launch one of the largest multiple myeloma surveys in the U.S. bit.ly/4tizSRU pic.x.com/8HyosXmyYb
Ready to see how you stack up to your industry’s top social performers? Review the latest metrics on channels, engagement, post types, and more.